INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P958. A total of 5 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $15,000 | -51.6% | 38,300 | +6.1% | 0.01% | -50.0% |
| Q3 2021 | $31,000 | +55.0% | 36,100 | +15.3% | 0.01% | +40.0% |
| Q2 2020 | $20,000 | -73.7% | 31,300 | +3.3% | 0.01% | -78.7% |
| Q1 2020 | $76,000 | +7500.0% | 30,300 | +4228.6% | 0.05% | +4600.0% |
| Q2 2019 | $1,000 | -99.4% | 700 | -99.2% | 0.00% | -99.0% |
| Q1 2019 | $172,000 | -85.6% | 92,611 | -34.3% | 0.10% | -89.4% |
| Q4 2018 | $1,195,000 | – | 141,000 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11,500 | $187,000 | 0.00% |
| SIMPLEX TRADING, LLC | 142,300 | $2,315,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 136,300 | $2,218,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |